Forte Biosciences, Inc. · NASDAQ:FBRX
Janus Henderson Group PLC reported a 9.99% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Janus Henderson Group PLC reported a 9.99% stake in Forte Biosciences, Inc., 1,387,178 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,387,178
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 9.99% | 1,387,178 |
Source
Related
- Forte Biosciences, Inc.
- Janus Henderson Group PLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 7, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026